Skip to main content

Table 2 Embryos outcomes of ovarian stimulation and PGT-A results

From: Euploidy rate and pregnancy outcomes in preimplantation genetic testing for aneuploidy cycles using progestin-primed ovarian stimulation versus GnRH antagonist protocol

 

PPOS group

GnRH antagonist group

P value

Oocytes at retrieval

12.70 ± 7.78

14.36 ± 8.63

0.013*

MII oocytes number

10.27 ± 6.59

11.60 ± 6.71

0.015*

Two pronuclei number

7.80 ± 4.91

8.90 ± 5.14

0.007*

D3 good quality embryo number

5.43 ± 3.79

6.37 ± 4.19

0.004*

Biopsied blastocyst number

3.51 ± 2.93

3.91 ± 3.19

0.116

good-quality blastocyst number

1.90 ± 2.24

2.22 ± 2.64

0.114

Euploid blastocyst rate (/biopsied blastocyst number)

43.3% (455/1050)

45.0% (526/1168)

0.423

Aneuploid blastocyst rate (/biopsied blastocyst number)

36.9% (387/1050)

36.0% (420/1168)

0.661

mosaic blastocyst rate (/biopsied blastocyst number)

19.4% (204/1050)

17.6% (206/1168)

0.127

WGA failure rate

0.4% (4/1050)

1.4% (16/1168)

0.025*

  1. WGA, whole genome amplification; *, P < 0.05